Business Description
Vitrolife AB
ISIN : SE0011205202
Total Employee Number:
1,126Compare
Compare
Traded in other countries / regions
VITR.SwedenVTFN.Germany0YAY.UKVTRLY.USA IPO Date
2016-01-06Description
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.56 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.2 | |||||
Debt-to-EBITDA | -0.34 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.56 | |||||
Beneish M-Score | -4.99 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.1 | |||||
3-Year EPS without NRI Growth Rate | -1.3 | |||||
3-Year FCF Growth Rate | -10.9 | |||||
3-Year Book Growth Rate | -22.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 21.54 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.77 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 9.55 | |||||
9-Day RSI | 33.39 | |||||
14-Day RSI | 44.05 | |||||
3-1 Month Momentum % | 11.49 | |||||
6-1 Month Momentum % | -29.97 | |||||
12-1 Month Momentum % | -22.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.68 | |||||
Quick Ratio | 2.96 | |||||
Cash Ratio | 1.5 | |||||
Days Inventory | 109.58 | |||||
Days Sales Outstanding | 68.97 | |||||
Days Payable | 45.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.04 | |||||
Dividend Payout Ratio | 0.38 | |||||
3-Year Dividend Growth Rate | 11.2 | |||||
Forward Dividend Yield % | 1.04 | |||||
5-Year Yield-on-Cost % | 1.04 | |||||
Shareholder Yield % | 3.24 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.67 | |||||
Operating Margin % | -142.1 | |||||
Net Margin % | -147.21 | |||||
EBITDA Margin % | -138.48 | |||||
FCF Margin % | 21.68 | |||||
OCF Margin % | 21.68 | |||||
ROE % | -45.01 | |||||
ROA % | -34.46 | |||||
ROIC % | -36.14 | |||||
3-Year ROIIC % | -1.02 | |||||
ROC (Joel Greenblatt) % | -441.17 | |||||
ROCE % | -34.68 | |||||
Years of Profitability over Past 10-Year | 8 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 29.69 | |||||
PE Ratio without NRI | 31.52 | |||||
PS Ratio | 3.62 | |||||
PB Ratio | 1.53 | |||||
Price-to-Free-Cash-Flow | 16.72 | |||||
Price-to-Operating-Cash-Flow | 16.72 | |||||
EV-to-EBIT | -2.65 | |||||
EV-to-Forward-EBIT | 19.39 | |||||
EV-to-EBITDA | -2.72 | |||||
EV-to-Forward-EBITDA | 11.84 | |||||
EV-to-Revenue | 3.77 | |||||
EV-to-Forward-Revenue | 3.71 | |||||
EV-to-FCF | 17.67 | |||||
Price-to-GF-Value | 0.65 | |||||
Price-to-Projected-FCF | 0.81 | |||||
Price-to-Median-PS-Value | 0.28 | |||||
Earnings Yield (Greenblatt) % | -37.67 | |||||
FCF Yield % | 6.09 | |||||
Forward Rate of Return (Yacktman) % | 7.81 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vitrolife AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 3,404 | ||
| EPS (TTM) (kr) | -37.01 | ||
| Beta | 1.4458 | ||
| 3-Year Sharpe Ratio | -0.55 | ||
| 3-Year Sortino Ratio | -0.68 | ||
| Volatility % | 45 | ||
| 14-Day RSI | 44.05 | ||
| 14-Day ATR (kr) | 0.072839 | ||
| 20-Day SMA (kr) | 105.75 | ||
| 12-1 Month Momentum % | -22.19 | ||
| 52-Week Range (kr) | 92.875 - 153.05 | ||
| Shares Outstanding (Mil) | 135.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vitrolife AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vitrolife AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-22 | In 106 days | ||
| Third quarter earnings results for 2026 | 2026-10-22 | In 106 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-16 | In 8 days | ||
| Second quarter earnings results for 2026 | 2026-07-16 | In 8 days | ||
| SEK 1.100000 Cash Dividend | 2026-05-06 | 111.05 (+0.00%) | ||
| General meeting for 2026 | 2026-05-05 17:00 | 111.05 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-04-23 10:00 | 94.85 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-23 08:00 | 94.85 (+0.00%) | ||
| Annual report for 2025 | 2026-03-26 | 94.85 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-01-29 | 151.00 (+0.00%) |
Show
Entries
Vitrolife AB Frequently Asked Questions
What is Vitrolife AB(CHIX:VITRs)'s stock price today?
The current price of CHIX:VITRs is kr105.75. The 52 week high of CHIX:VITRs is kr153.05 and 52 week low is kr92.88.
When is next earnings date of Vitrolife AB(CHIX:VITRs)?
The next earnings date of Vitrolife AB(CHIX:VITRs) is 2026-07-16.
Does Vitrolife AB(CHIX:VITRs) pay dividends? If so, how much?
The Dividend Yield %  of Vitrolife AB(CHIX:VITRs) is 1.04% (As of Today), Highest Dividend Payout Ratio of Vitrolife AB(CHIX:VITRs) was 0.38. The lowest was 0.21. And the median was 0.26. The  Forward Dividend Yield % of Vitrolife AB(CHIX:VITRs) is 1.04%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Vitrolife AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers